Bausch Health Cos Return on Investment 2012-2025 | BHC
Current and historical return on investment (ROI) values for Bausch Health Cos (BHC) over the last 10 years.
| Bausch Health Cos ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-12-31 | $1.81B | $20.95B | 8.65% |
| 2025-09-30 | $1.90B | $20.36B | 9.32% |
| 2025-06-30 | $1.60B | $20.36B | 7.84% |
| 2025-03-31 | $1.54B | $20.35B | 7.57% |
| 2024-12-31 | $1.55B | $20.44B | 7.56% |
| 2024-09-30 | $1.35B | $21.25B | 6.35% |
| 2024-06-30 | $1.05B | $21.47B | 4.87% |
| 2024-03-31 | $1.07B | $21.31B | 5.02% |
| 2023-12-31 | $0.96B | $21.06B | 4.57% |
| 2023-09-30 | $0.36B | $20.75B | 1.72% |
| 2023-06-30 | $0.59B | $20.64B | 2.84% |
| 2023-03-31 | $0.34B | $21.03B | 1.60% |
| 2022-12-31 | $0.45B | $21.69B | 2.09% |
| 2022-09-30 | $1.07B | $22.20B | 4.80% |
| 2022-06-30 | $1.40B | $22.45B | 6.21% |
| 2022-03-31 | $0.96B | $22.68B | 4.25% |
| 2021-12-31 | $0.45B | $22.82B | 1.97% |
| 2021-09-30 | $0.08B | $23.30B | 0.33% |
| 2021-06-30 | $-0.04B | $23.99B | -0.15% |
| 2021-03-31 | $0.21B | $24.51B | 0.84% |
| 2020-12-31 | $0.68B | $18.61B | 3.63% |
| 2020-09-30 | $-0.40B | $18.93B | -2.09% |
| 2020-06-30 | $-0.53B | $19.18B | -2.74% |
| 2020-03-31 | $-0.24B | $19.63B | -1.23% |
| 2019-12-31 | $-0.20B | $26.31B | -0.77% |
| 2019-09-30 | $0.90B | $26.58B | 3.38% |
| 2019-06-30 | $0.69B | $26.99B | 2.54% |
| 2019-03-31 | $0.18B | $27.42B | 0.67% |
| 2018-12-31 | $-2.38B | $28.19B | -8.46% |
| 2018-09-30 | $-2.73B | $29.26B | -9.33% |
| 2018-06-30 | $-2.81B | $30.26B | -9.29% |
| 2018-03-31 | $-2.39B | $31.07B | -7.69% |
| 2017-12-31 | $0.10B | $31.67B | 0.32% |
| 2017-09-30 | $0.57B | $32.15B | 1.79% |
| 2017-06-30 | $-0.33B | $32.91B | -0.99% |
| 2017-03-31 | $-0.42B | $34.03B | -1.24% |
| 2016-12-31 | $-0.57B | $35.26B | -1.61% |
| 2016-09-30 | $-0.55B | $36.05B | -1.52% |
| 2016-06-30 | $0.76B | $36.55B | 2.08% |
| 2016-03-31 | $1.02B | $36.72B | 2.79% |
| 2015-12-31 | $1.53B | $35.56B | 4.30% |
| 2015-09-30 | $1.97B | $31.65B | 6.21% |
| 2015-06-30 | $2.20B | $27.69B | 7.95% |
| 2015-03-31 | $2.22B | $24.09B | 9.20% |
| 2014-12-31 | $2.00B | $21.56B | 9.28% |
| 2014-09-30 | $1.62B | $22.00B | 7.36% |
| 2014-06-30 | $0.04B | $22.32B | 0.20% |
| 2014-03-31 | $-0.17B | $20.75B | -0.82% |
| 2013-12-31 | $-0.41B | $18.64B | -2.20% |
| 2013-09-30 | $-0.73B | $16.61B | -4.41% |
| 2013-06-30 | $0.19B | $13.88B | 1.36% |
| 2013-03-31 | $0.14B | $12.61B | 1.07% |
| 2012-12-31 | $0.08B | $11.86B | 0.67% |
| 2012-09-30 | $0.17B | $10.91B | 1.57% |
| 2012-06-30 | $0.25B | $10.41B | 2.44% |
| 2012-03-31 | $0.29B | $9.95B | 2.86% |
| 2011-12-31 | $0.30B | $9.57B | 3.12% |
| 2011-09-30 | $0.26B | $9.05B | 2.83% |
| 2011-06-30 | $0.02B | $8.86B | 0.20% |
| 2011-03-31 | $-0.05B | $6.98B | -0.73% |
| 2010-12-31 | $-0.11B | $5.05B | -2.18% |
| 2010-09-30 | $0.00B | $3.36B | -0.06% |
| 2010-06-30 | $0.18B | $1.25B | 14.58% |
| 2010-03-31 | $0.14B | $0.83B | 17.30% |
| 2009-12-31 | $0.18B | $0.42B | 43.65% |
| 2009-09-30 | $0.05B | 0 | 0.00% |
| 2009-06-30 | $0.05B | 0 | 0.00% |
| 2009-03-31 | $0.09B | 0 | 0.00% |
| 2008-12-31 | $0.10B | 0 | 0.00% |
| 2008-09-30 | $0.24B | 0 | 0.00% |
| 2008-06-30 | $0.25B | 0 | 0.00% |
| 2008-03-31 | $0.26B | 0 | 0.00% |
| 2007-12-31 | $0.29B | $0.34B | 86.90% |
| 2007-09-30 | $0.37B | $0.76B | 49.11% |
| 2007-06-30 | $0.45B | $1.18B | 38.20% |
| 2007-03-31 | $0.48B | $1.61B | 29.63% |
| 2006-12-31 | $0.46B | $1.70B | 26.93% |
| 2006-09-30 | $0.48B | $1.68B | 28.45% |
| 2006-06-30 | $0.47B | $1.67B | 28.08% |
| 2006-03-31 | $0.41B | $1.67B | 24.68% |
| 2005-12-31 | $0.35B | $1.62B | 21.88% |
| 2005-09-30 | $0.29B | $1.59B | 18.05% |
| 2005-06-30 | $0.22B | $1.18B | 18.59% |
| 2005-03-31 | $0.25B | $1.12B | 21.89% |
| 2004-12-31 | $0.27B | $1.15B | 23.09% |
| 2004-09-30 | $0.20B | $1.18B | 16.55% |
| 2004-06-30 | $0.18B | $1.60B | 11.50% |
| 2004-03-31 | $0.21B | $1.22B | 16.76% |
| 2003-12-31 | $0.21B | $1.18B | 18.12% |
| 2003-09-30 | $0.29B | $1.14B | 25.60% |
| 2003-06-30 | $0.33B | $1.08B | 30.66% |
| 2003-03-31 | $0.33B | $1.40B | 23.19% |
| 2002-12-31 | $0.33B | $1.39B | 24.03% |
| 2002-09-30 | $0.32B | $1.31B | 24.38% |
| 2002-06-30 | $0.30B | $1.15B | 25.67% |
| 2002-03-31 | $0.26B | $1.10B | 24.07% |
| 2001-12-31 | $0.25B | $0.95B | 26.52% |
| 2001-09-30 | $0.18B | $0.93B | 19.46% |
| 2001-06-30 | $0.15B | $0.88B | 17.46% |
| 2001-03-31 | $0.13B | $0.78B | 16.70% |
| 2000-12-31 | $0.10B | $0.76B | 13.21% |
| 2000-09-30 | $0.10B | $0.62B | 16.52% |
| 2000-06-30 | $0.09B | $0.53B | 16.40% |
| 2000-03-31 | $0.08B | $0.40B | 20.36% |
| 1999-12-31 | $0.08B | $0.28B | 28.73% |
| 1999-09-30 | $0.07B | $0.18B | 36.87% |
| 1999-06-30 | $0.06B | $0.16B | 37.58% |
| 1999-03-31 | $0.05B | $0.14B | 38.13% |
| 1998-12-31 | $0.05B | $0.12B | 40.16% |
| 1998-09-30 | $0.06B | $0.08B | 74.60% |
| 1998-06-30 | $0.07B | $0.05B | 123.22% |
| 1998-03-31 | $0.06B | $0.04B | 159.49% |
| 1997-12-31 | $0.06B | $0.03B | 246.46% |
| 1997-09-30 | $0.05B | $0.04B | 133.33% |
| 1997-06-30 | $0.03B | $0.05B | 71.51% |
| 1997-03-31 | $0.03B | $0.04B | 76.43% |
| 1996-12-31 | $0.04B | $0.03B | 140.54% |
| 1996-09-30 | $0.04B | $0.02B | 156.52% |
| 1996-06-30 | $0.03B | $0.01B | 244.44% |
| 1996-03-31 | $0.03B | $0.01B | 521.74% |
| 1995-12-31 | $0.02B | $0.01B | 365.22% |
| 1995-09-30 | $0.02B | $0.00B | 494.12% |
| 1995-06-30 | $0.02B | $0.00B | 517.65% |
| 1995-03-31 | $0.02B | $0.01B | 234.48% |
| 1994-12-31 | $0.01B | $0.01B | 179.31% |
| 1994-06-30 | $0.00B | $0.01B | 29.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |